DEA Looms Over Medical Marijuana Initiatives
The doctors weighed in on the status of medical marijuana in New York State at a recent event held by the New York chapter of Women Grow.
Covering topics including the Compassionate Care Act, dispensary management, and the integration of medical marijuana in to patient care for those with AIDS, cancer, Alzheimer’s, Crohn’s disease, migraines, and other illnesses brought a clear message of the pain relief and management benefits that derive from the plant.
Despite its touted applications, the recognition that marijuana remains listed as a Schedule I drug by the DEA was of course, recognized. New Yorkers, as are many in the medical profession across the country, however, are hopeful that further regulatory inroads can be made in to the medical space to allow for greater patient relief and care.
Have questions for us? Feel free to send them over using the Contact form above.